Vivos Therapeutics to Present at Upcoming SLEEP 2022 Annual Meeting
May 26, 2022 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., May 26, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos” or the “Company”), a medical technology company focused on developing and commercializing a...
Vivos Therapeutics Reports First Quarter 2022 Financial Results and Operational Update
May 16, 2022 16:05 ET
|
Vivos Therapeutics, Inc
First Quarter Appliance Revenue Increased 19% Year-Over-Year Management to Host Conference Call Today at 5:00 pm ET HIGHLANDS RANCH, Colo., May 16, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics,...
Vivos Therapeutics Schedules First Quarter 2022 Financial Results Conference Call
April 28, 2022 07:30 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., April 28, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Opens Third U.S. Multidisciplinary Center to Treat Patients Suffering from Sleep Apnea with The Vivos Method
April 26, 2022 08:26 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., April 26, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos'' or the “Company''), a medical technology company focused on developing and...
Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
March 31, 2022 16:05 ET
|
Vivos Therapeutics, Inc
Fourth Quarter Revenue Increased 33% Year-Over-Year While Full Year Revenue Increased 29% Management to Host Conference Call Today at 5:00 pm ET HIGHLANDS RANCH, Colo., March 31, 2022 (GLOBE...
Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call
March 31, 2022 08:14 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 31, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Fast Company Selects Vivos Therapeutics for 2022 “World’s Most Innovative Companies” List
March 08, 2022 09:11 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 08, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Rebrands Proprietary Clinical Protocol for Treating Patients with Breathing and Sleep Disorders
March 03, 2022 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 03, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics to Participate in Upcoming Investor Conferences
March 02, 2022 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 02, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics to Present at March 2022 World Sleep Congress in Rome
February 24, 2022 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...